New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization
Rheumatology and Therapy · 2024-08 · 11 (4) · 1001-1009
DOI: 10.1007/s40744-024-00682-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 14.06.2024. Verfasst von Jiale Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, 555 Youyi East Road, Nanshaomen, Xi'an, Shaanxi, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
INTRODUCTION: Research has highlighted the role of runt-related transcription factor 2 (Runx2) in the development of osteoarthritis (OA); however, its causal association remains unclear. This study aimed to explore whether Runx2 expression is causally associated with OA and assess its therapeutic potential for OA. METHODS: Genetic proxy instruments for Runx2 expression were obtained from gene expression quantitative trait locus (eQTLs) study of eQTLGen Consortium (n = 31,684). Aggregated genome-wide association study (GWAS) data for OA (including all OA [177,517 cases and 649,173 controls], knee OA (KOA) [62,497 cases and 333,557 controls], and hip OA (HOA) [36,445 cases and 316,943 controls]) were extracted from the Genetics of Osteoarthritis Consortium. We integrated eQTLs data with OA GWAS data to estimate their causal association and to estimate the potential of Runx2 as a drug target in the treatment of OA using summary data-based Mendelian randomization (SMR) analysis. Furthermore, different OA GWAS data (including all OA [77,052 cases and 378,169 controls], KOA [24,955 cases and 378,169 controls], and HOA [15,704 cases and 378,169 controls]) derived from the GWAS Catalog database were used for replication study. RESULTS: SMR analysis showed that high expression levels of Runx2 were associated with an increased risk of all OA [odds ratio (OR) 1.044, 95% confidence interval (CI) 1.023-1.067; P = 5.03 × 10-5], KOA (OR 1.040, 95% CI 1.006-1.075; P = 0.021), and HOA (OR 1.067, 95% CI 1.022-1.113; P = 0.003). This suggests that Runx2 inhibitors may have promising potential for the treatment of OA. Notably, the causal effects of Runx2 with all OA (OR 1.053, 95% CI 1.027-1.079; P = 3.95 × 10-5) and KOA (OR 1.043, 95% CI 1.001-1.087; P = 0.045) were repeated in the replication study, but limited evidence supported the association of Runx2 expression levels with HOA (OR 1.045, 95% CI 0.993-1.101; P = 0.094). CONCLUSIONS: Our analyses indicate a positive correlation between Runx2 expression and OA risk across all three phenotypes, suggesting the potential of Runx2 inhibitors in the treatment of OA and providing evidence from a genetic perspective.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, 555 Youyi East Road, Nanshaomen, Xi'an, Shaanxi, China.
- Department of Endocrinology, Xi'an Central Hospital, Xi'an, 710003, Shaanxi, China.
- Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, 555 Youyi East Road, Nanshaomen, Xi'an, Shaanxi, China. sousou369@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xie, J., Xu, X., Yang, M., Yu, H., Hao, J., Yang, D., & Xu, P. (2024). New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization. Rheumatology and Therapy, 11(4), 1001-1009. https://doi.org/10.1007/s40744-024-00682-1
Vancouver
Xie J, Xu X, Yang M, Yu H, Hao J, Yang D, et al. New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization. Rheumatology and Therapy. 2024;11(4):1001-1009. doi:10.1007/s40744-024-00682-1
BibTeX
@article{Xie2024,
author = {Xie, Jiale and Xu, Xin and Yang, Mingyi and Yu, Hui and Hao, Jinrong and Yang, Dinglong and Xu, Peng},
title = {New Insights on the Therapeutic Potential of Runt-Related Transcription Factor 2 for Osteoarthritis: Evidence from Mendelian Randomization},
journal = {Rheumatology and Therapy},
year = {2024},
volume = {11},
number = {4},
pages = {1001--1009},
doi = {10.1007/s40744-024-00682-1}
}
EUVIMED